Clinical Trial Update: Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases [Phase 1]

View source ↗

Summary

Phase 1 trial update for TK006 in breast cancer with bone metastases; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TK006

Snippet

Sponsor: Jiangsu T-Mab Biopharma Co.,Ltd | Conditions: Breast Cancer | Phase 1 | Status: UNKNOWN